For research use only. We do not sell to patients.

XY028-140

CAS No. : 2229974-83-6

Biological Activity：XY028-140 is a PROTAC connected by ligands for Cereblon and CDK. XY028-140 inhibits both CDK4/6 expression and CDK4/6 activity in cancer cells.

Research Area：Cancer

Targets：CDK|PROTACs

Related Screening Libraries:Bioactive Compound Library Plus;Cell Cycle/DNA Damage Compound Library;Kinase Inhibitor Library;Anti-Cancer Compound Library;Anti-Aging Compound Library;Anti-Breast Cancer Compound Library;Anti-Pancreatic Cancer Compound Library;Anti-Blood Cancer Compound Library;Cancer Stem Cells Compound Library;

Related Small Molecules:PROTAC Sirt2 Degrader-1;DB0614;Dinaciclib;SNS-032;CC-671;PROTAC VEGFR-2 degrader-2;(E/Z)-Zotiraciclib;dTAGV-1-NEG;CCT367766 formic;CDK1-IN-4;CCT-251921;BS-181;Samuraciclib hydrochloride hydrate;T025;HDAC6 degrader-1;Flavopiridol;CDK8-IN-3;PROTAC Axl Degrader 2;PhosTAC7;CDK9-IN-12;MS98;FLT3/CDK4-IN-1;GFB-12811;GSK 3 Inhibitor IX;JPS014;Eciruciclib;PROTAC PARP1 degrader;MD-224;CDK-IN-6

About Us:

MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
Structurally and synthetically diverse biologically active compounds；
roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；

Structurally and synthetically diverse biologically active compounds；

Customized order volume ranging from milligrams to kilograms scale；

We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.

Top Publications Citing Use of MCE Products